Search Results 331-340 of 18878 for alzheimers
Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition. Alzheimer's Disease ...
Polymorphism of the APOE gene is a major genetic determinant of late-onset Alzheimer's disease (AD). APOE4 confers up to a fifteen-fold greater risk of ...
The trial used Eli Lilly's drug solanezumab, an antibody, to try to target the building blocks of amyloid plaques in the brains of the those with Alzheimer's.
It's estimated that 5 million Americans age 65 and older may have Alzheimer's disease. And with an aging population on the rise, that number is expected to ...
Genome-wide association studies of late-onset Alzheimer's disease (LOAD) have identified many risk variants. The lab has assessed the association of the top ...
Learn about gene expression studies related to neurodegenerative diseases at Mayo Clinic's Genetics of Alzheimer's Disease and Endophenotypes Lab.
It was 33 years ago that President Ronald Reagan launched the first national Alzheimer's disease awareness campaign. Since then, research has developed ways ...
Read news articles about the Mayo Clinic Study of Aging and find research updates and healthy aging information in the study newsletter, Mindful Matters.
A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease ... Alzheimer's Disease (EOAD) using a 48-hour CAA-EEG.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.